Head Neck. 2016;38(2):277-84.
Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience.
제1저자 옥찬영 · 교신저자 김범석
소속 (4)
- Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
- Department of Otorhinolaryngology, Seoul National University Hospital, Seoul, South Korea.
- Department of Radiation Oncology, Seoul National University Hospital, Seoul, South Korea.
Abstract
BACKGROUND Although induction chemotherapy can reduce distant metastases in locally advanced head and neck squamous cell carcinoma (HNSCC), overall survival (OS) improvement because of induction chemotherapy has not been confirmed.
METHODS We reviewed medical records of 224 patients diagnosed with locally advanced HNSCC who were treated with induction chemotherapy followed by concurrent chemoradiotherapy (CRT; induction chemotherapy/CRT; N = 144) and CRT alone (N = 80) from 2005 to 2013. We analyzed OS and progression-free survival (PFS).
RESULTS The 3-year OS rate was significantly higher in the induction chemotherapy/CRT group compared to the CRT group (74.0% vs 62.7%; p = .045). The 3-year PFS rate was 64.6% in the induction chemotherapy/CRT group and 54.1% in the CRT group (p = .060). Subgroup analysis showed patients with high N classification (N2 or N3) oropharyngeal cancer had greater benefits when treated with induction chemotherapy/CRT.
CONCLUSION Induction chemotherapy plus CRT improved OS, compared to CRT alone in locally advanced HNSCC, especially with high N classification.
© 2015 Wiley Periodicals, Inc.
Keywords
concurrent chemoradiotherapyhead and neck cancerinduction chemotherapysubgroup analysissurvival
그 밖의 정보
- 출판 형태
- Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
- 저널
- Head & neck · eISSN 1097-0347
- 전자 출판
- 2015-06-18
- MeSH
- Adult · Aged · Aged, 80 and over · Carcinoma, Squamous Cell / mortality / therapy · Chemoradiotherapy* · Disease Progression · Female · Head and Neck Neoplasms / mortality / therapy · Humans · Induction Chemotherapy* · Male · Middle Aged · Propensity Score · Retrospective Studies · Young Adult